Ipsen Regulated Information | Investor Relations

Regulated Information
Shareholders Meeting

Period

Filter by

Reset

Showing: 1 – 05 of 145 Regulated Information

Show

Sort

IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2025

28 October 2025

IPSEN – Buy-back programme – Art 5 of MAR – Week 43 – 2025

Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline

22 October 2025

Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline

PARIS AND MARSEILLE, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) and ImCheck Therapeutics today announced they have entered into a definitive share purchase agreement in which Ipsen will acquire all issued and outstanding shares of ImCheck Therapeutics,…